Emyria Ltd
ASX:EMD
Prices of ASX stocks are not being updated. The latest EMD price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Emyria Ltd
ASX:EMD
|
AU |
|
M
|
Miss Grand International PCL
SET:MGI
|
TH |
|
F
|
Fintec Global Bhd
KLSE:FINTEC
|
MY |
|
Absa Group Ltd
F:AU6
|
ZA |
|
B
|
Bonterra Energy Corp
OTC:BNEFF
|
CA |
|
Fineos Corporation Holdings PLC
F:0M9
|
IE |
|
M
|
Mitra Adiperkasa Tbk PT
F:QGI
|
ID |
|
P
|
Polaris Inc
F:PL6
|
US |
|
Marketaxess Holdings Inc
NASDAQ:MKTX
|
US |
|
Agree Realty Corp
F:AGL
|
US |
|
MVB Financial Corp
F:MV6
|
US |
|
S
|
Sierra Bancorp
NASDAQ:BSRR
|
US |
|
Donskoy Zavod Radiodetaley OAO
MOEX:DZRD
|
RU |
|
Kinross Gold Corp
TSX:K
|
CA |
|
F
|
Felix Gold Ltd
OTC:FXGDF
|
AU |
Bankruptcy Probability
Emyria Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Emyria Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Emyria Ltd
ASX:EMD
|
32.3m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
366.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
174.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
202.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Emyria Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Emyria Ltd has total debt of 660.6k AUD. This includes both short-term (0 AUD) and long-term (660.6k AUD) debt.
You can find a full breakdown on its Balance Sheet.
